TrialBMC cancer2016

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trial.

Christiane Thallinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.